Total Credits: .75 including .75 AOA Category 1-A Credit(s)
Watchful waiting is the recommended strategy for patients with BPH who have mild symptoms and for those with moderate-to-severe symptoms who are not bothered by their symptoms and are not experiencing complications of BPH. In those patients, medical therapy is not likely to improve their symptoms and/or quality of life. In addition, the risks of treatment may outweigh any benefits in such cases. This session will review the most commonly offered treatment options currently available.
At the conclusion of this session, the participant should be able to:
- Review the history of BPH.
- Describe the current management and treatment of BPH.
- Distinguish the difference between pharmacotherapy and minimally invasive treatment options.
Disclosure Statement: Dr. Ghiraldi, faculty for this educational event, has no relevant financial relationship(s) with ineligible companies to disclose.
Accreditation Statement: The Pennsylvania Osteopathic Medical Association (POMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. POMA designates this activity for a maximum of 0.75 Category 1-A AOA CME credits and will report CME and specialty credits to the AOA commensurate with the extent of the physician’s participation in this activity.
Grievance Statement: If you are not satisfied with the program, you may file a written grievance by emailing cme@poma.org. Your complaint will be forwarded to the Education Committee for review. The committee will determine if the participant should be reimbursed with no credits or deny the complaint and take the issue into consideration for future programs.
| GhiraldiEricHandout (2.3 MB) | Available after Purchase | ||
Eric M. Ghiraldi, DO, “Contemporary Management of Benign Prostatic Hyperplasia: Laser, Waterjets, Water Vapor Replacing Conventional Treatment,” is a physician with Fox Chase Cancer Center in Rockledge, Pennsylvania and Temple Health, Fort Washington. Board certified in urology, Dr. Ghiraldi is a graduate of New York Institute of Technology and a 2015 graduate of New York College of Osteopathic Medicine in Old Westbury, New York. He completed a urology residency at Einstein Healthcare Network in Philadelphia, and an endourology fellowship at Yale School of Medicine in New Haven, Connecticut.
He has no relevant financial relationship(s) with ineligible companies to disclose.
|
Current Screening for High School and College Athletes, Including Sudden Death in Sports
Original Program Date: 05/03/2023 |
|
Update in the Management of Congestive Heart Failure with Reduced Ejection Fraction in 2023
Original Program Date: 05/03/2023 |
|
Current Medical, Endovascular and Surgical Management of Carotid Artery Disease
Original Program Date: 05/03/2023 |
|
An Interdisciplinary Approach to Metabolic Disease Management with Cultural Considerations
Original Program Date: 05/04/2023 |